Dr. Sulaiman Al Habib Medical Services Group Company
4013.SRSAUHealthcare● Active
$218.70
+$2.50(+1.16%)
Market Cap$76.5B
P/E Ratio—
52W High$281.2
52W Low$211.5
Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4013.SR · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $2.40B | $2.41B | $2.05B | $1.80B | $1.50B |
| Depreciation & Amort. | $0.67B | $0.42B | $0.31B | $0.31B | $0.31B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.36B) | ($0.35B) | $0.42B | $0.52B | $0.15B |
| Net Cash from Operations | $3.08B | $2.97B | $3.24B | $2.84B | $2.18B |
| Investing Activities | |||||
| Capital Expenditure | ($2.98B) | ($3.83B) | ($3.50B) | ($1.51B) | ($1.25B) |
| Purchases of Investments | ($0.00B) | $0.00B | $0.00B | ($0.30B) | $0.00B |
| Sales of Investments | $0.00B | $0.04B | $0.00B | $0.03B | $0.00B |
| Net Cash from Investing | ($2.99B) | ($3.78B) | ($3.49B) | ($1.94B) | ($1.25B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($1.66B) | ($1.64B) | ($1.44B) | ($1.14B) | ($0.94B) |
| Debt Issued / Repaid | $1.07B | $2.85B | $1.70B | $0.43B | $0.40B |
| Net Cash from Financing | ($0.71B) | $1.08B | $0.18B | ($0.80B) | ($0.63B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.10B | ($0.86B) | ($0.30B) | $1.33B | $0.93B |
| FCF Margin %(computed) | 0.74% | -7.66% | -3.20% | 16.01% | 12.82% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Dr. Sulaiman Al Habib Medical Services Group Company data
About Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) Cash Flow Statement
Dr. Sulaiman Al Habib Medical Services Group Company generated operating cash flow of $3.08B and free cash flow of $0.10B for 2025 — a FCF margin of 0.74%. Capital expenditure was ($2.98B).
Frequently asked questions
4013.SR · 4 questionsDr. Sulaiman Al Habib Medical Services Group Company generated free cash flow of $0.10B for 2025, up 111.8% year-over-year.
4013.SR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15